Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ethical Dilemmas I01:17

Ethical Dilemmas I

Ethical dilemmas in nursing are of utmost importance, as they often arise from the tension between adhering to core ethical principles and the practical realities of healthcare delivery. These dilemmas require nurses to navigate complex situations where competing ethical considerations pull them in different directions.
Let us explore some examples to understand the potentially complex moral decisions nurses face.
Take the case of caring for minors, particularly in areas related to reproductive...
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
Ethical Issues01:27

Ethical Issues

Nurses are essential in patient care, upholding the ethical principles of their profession and effectively navigating ethical dilemmas. Neglecting ethical issues can lead to inadequate patient care, compromised therapeutic relationships, and moral distress among healthcare workers.
Ethical Concerns in Healthcare:
Ethical Dilemmas II01:30

Ethical Dilemmas II

Resolving an ethical dilemma in healthcare involves a systematic approach that considers every aspect of the issue, respecting both the patient's needs and values and the healthcare professional's ethical obligations. Here are potential steps to resolve an ethical dilemma:
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

IMPACT (Immune Monitoring and Phenotype Assessment of Clinical Trajectory) for Patients With Inborn Errors of Immunity From the Primary Immune Deficiency Treatment Consortium (PIDTC).

The journal of allergy and clinical immunology. In practice·2026
Same author

Evaluating the impact of leniolisib treatment on symptoms and health-related quality of life in activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome.

Frontiers in immunology·2026
Same author

X-linked SEPTIN6-related congenital neutropenia and B cell deficiency.

Journal of human immunity·2026
Same author

Author Correction: Multi-omic profiling reveals age-related immune dynamics in healthy adults.

Nature·2026
Same author

Preclinical efficacy and safety assessment of engineered regulatory T cells for treatment of IPEX and other autoimmune disorders.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

The 2024 update of IUIS phenotypic classification of human inborn errors of immunity.

Journal of human immunity·2026
Same journal

Facial Dysmorphism and Severe Vascular Phenotype in TRNT1 Deficiency with Concomitant Antithrombin III Deficiency.

Journal of clinical immunology·2026
Same journal

Intersection Between Systemic Autoimmune Diseases, Primary Immunodeficiency and Cancer: a Field in its Infancy.

Journal of clinical immunology·2026
Same journal

Disseminated Tuberculosis and Early-Onset SLE in a Child with a Novel STAT1 Gain-of-Function Mutation: a Case Report.

Journal of clinical immunology·2026
Same journal

Humoral Immune Abnormalities in Transient Childhood Neutropenia: Insights From a 10-year Cohort Study in a Tertiary Center.

Journal of clinical immunology·2026
Same journal

Correction to: Whole Genome Sequencing in 25 Families with Suspected Inborn Errors of Immunity: Diagnostic Yield and Clinical Relevance of Genome-wide Analysis.

Journal of clinical immunology·2026
Same journal

Hypoproteinemia and Hypogammaglobulinemia Due to a Homozygous FCGRT Mutation.

Journal of clinical immunology·2026
See all related articles

Related Experiment Video

Updated: May 16, 2026

Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods
13:04

Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods

Published on: September 19, 2012

Clinical ambiguities--ongoing questions.

Troy R Torgerson1, Vincent R Bonagura, Ralph S Shapiro

  • 1University of Washington School of Medicine, 1900 9th Ave., C9S-7, Seattle, WA 98101-1304, USA. troy.torgerson@seattlechildrens.org

Journal of Clinical Immunology
|December 18, 2012
PubMed
Summary
This summary is machine-generated.

Choosing between intravenous immunoglobulin (IVIG) and subcutaneous immunoglobulin (SCIG) for primary immunodeficiency disease (PIDD) replacement therapy can be complex. This article clarifies ambiguous clinical scenarios to aid in selecting the optimal IgG delivery method.

More Related Videos

Perceptual and Category Processing of the Uncanny Valley Hypothesis' Dimension of Human Likeness: Some Methodological Issues
07:34

Perceptual and Category Processing of the Uncanny Valley Hypothesis' Dimension of Human Likeness: Some Methodological Issues

Published on: June 3, 2013

Related Experiment Videos

Last Updated: May 16, 2026

Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods
13:04

Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods

Published on: September 19, 2012

Perceptual and Category Processing of the Uncanny Valley Hypothesis' Dimension of Human Likeness: Some Methodological Issues
07:34

Perceptual and Category Processing of the Uncanny Valley Hypothesis' Dimension of Human Likeness: Some Methodological Issues

Published on: June 3, 2013

Area of Science:

  • Immunology
  • Pharmacology
  • Clinical Medicine

Background:

  • Primary immunodeficiency diseases (PIDD) often require immunoglobulin (IgG) replacement therapy.
  • The choice between intravenous IgG (IVIG) and subcutaneous IgG (SCIG) delivery methods involves multiple patient-specific factors.
  • Existing guidance leaves some clinical situations ambiguous regarding optimal IgG therapy administration.

Purpose of the Study:

  • To provide clarification and address ongoing questions regarding the selection of IgG replacement therapy modes.
  • To assist clinicians in making informed decisions for patients with PIDD where IVIG versus SCIG choice is unclear.

Main Methods:

  • Review of current clinical guidelines and literature.
  • Analysis of factors influencing the choice between IVIG and SCIG.
  • Discussion of specific ambiguous clinical scenarios.

Main Results:

  • Identification of key factors influencing IVIG vs. SCIG selection.
  • Elucidation of optimal strategies for ambiguous clinical presentations.
  • Framework for personalized IgG therapy delivery.

Conclusions:

  • Optimizing IgG replacement therapy requires careful consideration of individual patient needs and specific clinical contexts.
  • Clearer guidance on IVIG vs. SCIG selection can improve patient outcomes in PIDD.
  • Further research may be warranted for complex or rare cases.